TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · IEX Real-Time Price · USD
6.92
0.00 (0.00%)
At close: Jul 19, 2024, 4:00 PM
7.00
+0.08 (1.16%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $365.81 million as of July 22, 2024. Its market cap has increased by 545.17% in one year.
Market Cap
365.81M
Enterprise Value
289.76M
1-Year Change
545.17%
Ranking
Category
Stock Price
$6.92
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has increased from $359.08M to $365.81M, an increase of 1.88%. That is a compound annual growth rate of 0.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 365.80M | 31.21% |
| Dec 29, 2023 | 278.80M | 647.45% |
| Dec 30, 2022 | 37.30M | -65.14% |
| Dec 31, 2021 | 107.00M | -70.20% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revance Therapeutics | 379.67M |
| Sight Sciences | 378.65M |
| Tourmaline Bio | 377.26M |
| uniQure | 375.77M |
| Lexeo Therapeutics | 368.66M |
| Talkspace | 358.04M |
| Vanda Pharmaceuticals | 355.59M |
| Q32 Bio | 351.81M |